TABLE OF CONTENTS
Volume 12, Issue 2 (June 2009)
Editorial
Report from London FREE
R Kirby Co-Editor
Prostate Cancer Prostatic Dis 12: 105; doi:10.1038/pcan.2009.14
Research Highlights
Prostate News FREE
Prostate Cancer Prostatic Dis 12: 106-109; doi:10.1038/pcan.2009.13
Reviews
Exercise therapy across the prostate cancer continuum
J Antonelli, S J Freedland and L W Jones
Prostate Cancer Prostatic Dis 12: 110-115; advance online publication, March 10, 2009; doi:10.1038/pcan.2009.4
Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy
H Van Poppel, S Joniau, B Van Cleynenbreugel, F M Mottaghy and R Oyen
Prostate Cancer Prostatic Dis 12: 116-123; advance online publication, February 24, 2009; doi:10.1038/pcan.2009.3
Salvage HIFU for recurrent prostate cancer after radiotherapy
V Chalasani, C H Martinez, D Lim and J Chin
Prostate Cancer Prostatic Dis 12: 124-129; advance online publication, October 14, 2008; doi:10.1038/pcan.2008.53
5
-Reductase inhibitor treatment of prostatic diseases: background and practical implications
J Dörsam and J Altwein
Prostate Cancer Prostatic Dis 12: 130-136; advance online publication, November 25, 2008; doi:10.1038/pcan.2008.56
Original Articles
Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen
N B Delongchamps, G de la Roza, V Chandan, R Jones, G Threatte, M Jumbelic and G P Haas
Prostate Cancer Prostatic Dis 12: 137-142; advance online publication, July 15, 2008; doi:10.1038/pcan.2008.38
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, C Corbishley, D Dearnaley, R Eeles, V Khoo, R Huddart, A Horwich, A Thompson, A Norman, D Brewer, C S Cooper and C Parker
Prostate Cancer Prostatic Dis 12: 143-147; advance online publication, September 2, 2008; doi:10.1038/pcan.2008.47
The patients less than 50 years: is there a need to lower the PSA cutoff point?
I A Hekal
Prostate Cancer Prostatic Dis 12: 148-151; advance online publication, September 30, 2008; doi:10.1038/pcan.2008.48
Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH
B-H Chung, C G Roehrborn, P Siami, K Major-Walker, B B Morrill, T H Wilson and F Montorsi on behalf of the CombAT Study Group
Prostate Cancer Prostatic Dis 12: 152-159; advance online publication, September 23, 2008; doi:10.1038/pcan.2008.49
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
J Hammarsten, J-E Damber, M Karlsson, T Knutson, Ö Ljunggren, C Ohlsson, R Peeker, U Smith and D Mellström
Prostate Cancer Prostatic Dis 12: 160-165; advance online publication, September 30, 2008; doi:10.1038/pcan.2008.50
Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer
F J Zhao, S Zhang, Z M Yu, S J Xia and H Li
Prostate Cancer Prostatic Dis 12: 166-171; advance online publication, July 15, 2008; doi:10.1038/pcan.2008.39
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database
J L Nelles, S J Freedland, J C Presti Jr, M K Terris, W J Aronson, C L Amling and C J Kane
Prostate Cancer Prostatic Dis 12: 172-176; advance online publication, July 15, 2008; doi:10.1038/pcan.2008.40
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes
D A Shoskes, J C Nickel, R R Rackley and M A Pontari
Prostate Cancer Prostatic Dis 12: 177-183; advance online publication, July 22, 2008; doi:10.1038/pcan.2008.42
An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer
P L Paris, S Sridharan, A B Hittelman, Y Kobayashi, S Perner, G Huang, J Simko, P Carroll, M A Rubin and C Collins
Prostate Cancer Prostatic Dis 12: 184-191; advance online publication, September 9, 2008; doi:10.1038/pcan.2008.45
Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis
L M FitzGerald, E Karlins, D M Karyadi, E M Kwon, J S Koopmeiners, J L Stanford and E A Ostrander
Prostate Cancer Prostatic Dis 12: 192-197; advance online publication, September 2, 2008; doi:10.1038/pcan.2008.46
Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
D A Galvão, D R Taaffe, N Spry, D Joseph, D Turner and R U Newton
Prostate Cancer Prostatic Dis 12: 198-203; advance online publication, October 14, 2008; doi:10.1038/pcan.2008.51
Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy
A Sankin, B Tareen and H Lepor
Prostate Cancer Prostatic Dis 12: 204-208; advance online publication, February 24, 2009; doi:10.1038/pcan.2009.2
